ClariTrial | Search Clinical Trials

Explore/Cancer

Status

Phase

142,654 results for “Cancer”

Page 1 of 9511

Completed

Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System

N/ATraumaTumorPseudarthrosis

VueLock™ Anterior Cervical Plate

Zimmer Biomet371 participants4 sites · United StatesCompletes Sep 2009

Compare CT.gov Full analysis →

Completed

Results posted

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

Phase 2External Genital Warts

Investigational TreatmentAldara

Novartis Pharmaceuticals88 participants1 site · United StatesCompletes May 2016

Compare CT.gov Full analysis →

Completed

Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients

N/ANeoplasmsNervous System DiseaseVestibular Disease

National Institute of Neurological Disorders and Stroke (NINDS)5 participants1 site · United States

Compare CT.gov Full analysis →

Terminated

Results posted

Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients

Phase 3Gastrointestinal Stromal Tumors

Imatinib mesylateImatinib mesylateImatinib mesylate

Sarcoma Alliance for Research through Collaboration5 participants13 sites · United StatesCompletes Jun 2011

Compare CT.gov Full analysis →

Completed

QYJD Compound Preparation Promotes Rapid Postoperative Recovery in Early-stage NSCLC Patients by Regulating Tissue Microecology: a Prospective, Randomized Controlled, Open-label, Phase I Clinical Study With Predefined Future Exploration

Phase 1NSCLC

QYJD Compound Preparation

Fuzhou General Hospital15 participants1 site · ChinaCompletes Dec 2022

Compare CT.gov Full analysis →

Completed

Temsirolimus In Phase 0

Early Phase 1Advanced Cancer

Temsirolimus

M.D. Anderson Cancer Center15 participants1 site · United StatesCompletes Jun 2014

Compare CT.gov Full analysis →

Completed

Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Phase 1Acute Myeloid LeukemiaMyelodysplastic Syndrome

Lenalidomide

University of California, Davis16 participants1 site · United StatesCompletes Jun 2018

Compare CT.gov Full analysis →

Completed

Effects of NMES and Exercise in Hematological Cancer

N/AHematologic MalignancyMuscle Weakness

Neuromuscular Electrical StimulationStructured Exercise

Acibadem University31 participants1 site · Turkey (Türkiye)Completes Nov 2021

Compare CT.gov Full analysis →

Not Yet Recruiting

Walking and Sitting Difficulties After Rectal Cancer Surgery

N/ARectal Cancer PatientsRectal Cancer SurgeryRectal Cancer, Radiotherapy

Targeted leaderled training programControl arm with WHO recommendation on physical activity

Sahlgrenska University Hospital300 participants1 site · SwedenCompletes Oct 2029

Compare CT.gov Full analysis →

Withdrawn

Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

Early Phase 1Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8

AtezolizumabCryosurgeryNab-paclitaxel

Mayo Clinic0Completes Nov 2021

Compare CT.gov Full analysis →

Completed

Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia

Phase 2Chronic Myeloproliferative DisordersSecondary Myelofibrosis

cyclophosphamideprednisonethalidomide+3 more

Mayo Clinic22 participantsCompletes Oct 2006

Compare CT.gov Full analysis →

Withdrawn

Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies

Phase 4Liver Cancer

TriNavTraditional DeliveryDoxorubicin

Dana-Farber Cancer Institute01 site · United StatesCompletes Feb 2025

Compare CT.gov Full analysis →

UNKNOWN

Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects

Phase 1Phase 2Relapsed/Refractory B Cell MalignanciesMantle Cell Lymphoma and Diffuse Large B Cell LymphomaChronic Lymphocytic Leukemia

TL-895Navtemadlin

Telios Pharma, Inc.130 participants17 sites · United States, Hungary, ItalyCompletes Dec 2024

Compare CT.gov Full analysis →

Recruiting

Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer

Phase 2Pancreatic Cancer

SHR-A2102 or/and HRS-4642SHR-A1904 or/and HRS-4642SHR-A1811 or/and HRS-4642+1 more

Fudan University160 participants1 site · ChinaCompletes Mar 2027

Compare CT.gov Full analysis →

Completed

Results posted

Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention

N/AHuman PapillomavirusHuman Immunodeficiency VirusHepatitis C

OraQuick SwabFecal Immunochemical TestOraQuick Fingerstick+3 more

University of Miami754 participants1 site · United StatesCompletes Oct 2020

Compare CT.gov Full analysis →

1–15 of 142,654

Explore/Cancer

Status

Phase

142,654 results for “Cancer”

Page 1 of 9511

Completed

Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System

N/ATraumaTumorPseudarthrosis

VueLock™ Anterior Cervical Plate

Zimmer Biomet371 participants4 sites · United StatesCompletes Sep 2009

Compare CT.gov Full analysis →

Completed

Results posted

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

Phase 2External Genital Warts

Investigational TreatmentAldara

Novartis Pharmaceuticals88 participants1 site · United StatesCompletes May 2016

Compare CT.gov Full analysis →

Completed

Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients

N/ANeoplasmsNervous System DiseaseVestibular Disease

National Institute of Neurological Disorders and Stroke (NINDS)5 participants1 site · United States

Compare CT.gov Full analysis →

Terminated

Results posted

Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients

Phase 3Gastrointestinal Stromal Tumors

Imatinib mesylateImatinib mesylateImatinib mesylate

Sarcoma Alliance for Research through Collaboration5 participants13 sites · United StatesCompletes Jun 2011

Compare CT.gov Full analysis →

Completed

Phase 1NSCLC

QYJD Compound Preparation

Fuzhou General Hospital15 participants1 site · ChinaCompletes Dec 2022

Compare CT.gov Full analysis →

Completed

Temsirolimus In Phase 0

Early Phase 1Advanced Cancer

Temsirolimus

M.D. Anderson Cancer Center15 participants1 site · United StatesCompletes Jun 2014

Compare CT.gov Full analysis →

Completed

Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Phase 1Acute Myeloid LeukemiaMyelodysplastic Syndrome

Lenalidomide

University of California, Davis16 participants1 site · United StatesCompletes Jun 2018

Compare CT.gov Full analysis →

Completed

Effects of NMES and Exercise in Hematological Cancer

N/AHematologic MalignancyMuscle Weakness

Neuromuscular Electrical StimulationStructured Exercise

Acibadem University31 participants1 site · Turkey (Türkiye)Completes Nov 2021

Compare CT.gov Full analysis →

Not Yet Recruiting

Walking and Sitting Difficulties After Rectal Cancer Surgery

N/ARectal Cancer PatientsRectal Cancer SurgeryRectal Cancer, Radiotherapy

Targeted leaderled training programControl arm with WHO recommendation on physical activity

Sahlgrenska University Hospital300 participants1 site · SwedenCompletes Oct 2029

Compare CT.gov Full analysis →

Withdrawn

Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

Early Phase 1Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8

AtezolizumabCryosurgeryNab-paclitaxel

Mayo Clinic0Completes Nov 2021

Compare CT.gov Full analysis →

Completed

Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia

Phase 2Chronic Myeloproliferative DisordersSecondary Myelofibrosis

cyclophosphamideprednisonethalidomide+3 more

Mayo Clinic22 participantsCompletes Oct 2006

Compare CT.gov Full analysis →

Withdrawn

Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies

Phase 4Liver Cancer

TriNavTraditional DeliveryDoxorubicin

Dana-Farber Cancer Institute01 site · United StatesCompletes Feb 2025

Compare CT.gov Full analysis →

UNKNOWN

Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects

Phase 1Phase 2Relapsed/Refractory B Cell MalignanciesMantle Cell Lymphoma and Diffuse Large B Cell LymphomaChronic Lymphocytic Leukemia

TL-895Navtemadlin

Telios Pharma, Inc.130 participants17 sites · United States, Hungary, ItalyCompletes Dec 2024

Compare CT.gov Full analysis →

Recruiting

Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer

Phase 2Pancreatic Cancer

SHR-A2102 or/and HRS-4642SHR-A1904 or/and HRS-4642SHR-A1811 or/and HRS-4642+1 more

Fudan University160 participants1 site · ChinaCompletes Mar 2027

Compare CT.gov Full analysis →

Completed

Results posted

Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention

N/AHuman PapillomavirusHuman Immunodeficiency VirusHepatitis C

OraQuick SwabFecal Immunochemical TestOraQuick Fingerstick+3 more

University of Miami754 participants1 site · United StatesCompletes Oct 2020

Compare CT.gov Full analysis →

1–15 of 142,654